Nicotine dependence and neuropsychotic effects of varenicline

• Main Authors: T. M. Bukatina (Author), A. S. Kazakov (Author), R. N. Alyautdin (Author), T. V. Romanova (Author), I. I. Snegireva (Author)
• Formato: Livro
• Publicado em: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Varenicline is a partial agonist of nicotinic acetylcholine receptors for the therapy of nicotine addiction. The efficacy and safety of the use of varenicline in the treatment of nicotine dependence have been demonstrated in clinical trial EAGLES. These studies describe adverse reactions such us men...